首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress an
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress an
admin
2010-05-14
89
问题
Growing concerns over the safety and efficacy of anti-depressant drugs prescribed to children have caught the eye of Congress and the New York state attorney general. Now they’re becoming the catalyst for calls to reform the way clinical trials of all drugs are reported.
Pressure is already causing some changes within the pharmaceutical industry. And it has put the US Food and Drug Administration (FDA), which approves new drugs, in the hot seat. If reforms are carried out, they could bring an unprecedented level of transparency to drug research.
The solution now under consideration: a public database, or registry, of drug trials, where companies would post the results of those trials.
In congressional testimony Thursday, a spokesman for the American Medical Association endorsed the registry and said it should include information on each trial’ s purpose and objective, its design, and the dates it begins and ends. If the trial is not completed, the registry should include an explanation.
While drug companies have been eager to make public any positive results of their trials, recent revelations suggest they’ ye balked at divulging tests when the results are not what they’ d hoped to see. The furor has centered around the use of anti- depressants on children.
The industry has begun to make some moves to address the concerns about drug trials. Drug companies have agreed to set up a voluntary system of posting their drug trials on the Intemet. But that seems unlikely to satisfy some members of Congress, who are expected to introduce legislation to establish a mandatory drug registry.
Last week, editors of a dozen influential medical journals announced that they would begin requiring drug companies to post a drug trial in a public database prior to accepting an article about it. Doctors rely on these articles to make treatment choices. The editors hope that the registry will force unfavorable drug studies, before kept secret, into the open.
Medical journals already had been tightening up on the authorship of their articles, insisting that authors declare if they had any conflicts of interest, such as any financial or other ties to the drug company, says Daniel Callahan, a director at the Hastings Center, a nonprofit bioethics research institute in Garrison, N.Y.
Information from previously undisclosed clinical trials could lower prices, reduce the number of badly designed trials, and help doctors considering the use of a drug for a non-approved purpose to know why it hasn’t been approved for that use.
Antidepressant drugs "have some serious side effects... that seem to be much more common than people realize... much more common than you might think from seeing drug ads and from reports on drug studies," says Joel Gurin, executive vice president of Consumer Reports. His magazine just finished a survey of readers showing a "dramatic shift from talk therapy to drug therapy for mental health problems" during the past decade. In 1995, less than half of people getting mental health treatment—40 percent—got drug therapy. Today 68 percent receive drug treatment, Mr. Gurin says.
Some studies coming to light show that antidepressants work no better than placebos. Even better than merely registering drug trials, Caplan (director of the Center for Bioethics at the University of Pennsylvania in Philadelphia) suggests, would be to require that a new drug not only be "safe and do what it’ s sup posed to do", but that it do it as well or better than other drugs already on the market. That, he says, would help push research into new areas and save money.
Who is willingly to introduce the registry of drug trials?
选项
A、The pharmaceutical industry.
B、US Food and Drug Administration.
C、The Congress.
D、The drug companies.
答案
C
解析
下面哪一方是愿意引进药品临床试验结果登记这一方法的?由第二段可知,pharmaceutical industry和US Food and Drug Administration都是迫于压力的,更不用说此方法会对其产生不利的药品公司了。
转载请注明原文地址:https://www.kaotiyun.com/show/gpqO777K
0
专业英语八级
相关试题推荐
ToparaphraseMartinLutherKing—hereatlast,hereatlast,hereatlast.Almostacenturyaftertheideawasfirstmootedbyb
HungerandfoodinsecurityhavebeencalledAmerica’s"hiddencrisis."Atthesametime,andapparentlyparadoxically,obesity
Modernintelligencetestingbeganin【B1】______.FrenchpsychologistBinetbasedhistestonthetheorythatintelligenceincreas
Evenaspharmaceuticalcompaniespouredarecordamountofmoneyintodrugdevelopmentin2005,theindustry’sresearchdrought
EatingouthasbecomeasAmericanasapplepie,butforthosemanningthekitchen,restaurantworkisanythingbutanAmericand
“新北京,新奥运”表达了我们在新世纪里,由一个既有古老文化传统又具有现代化魅力的城市来举办一届伟大的奥运会的愿望。我们申办的三个主题为绿色奥运、科技奥运和人文奥运。我们的目标是在我们的人民,尤其是在4亿青少年中传播奥林匹克理想。届时,我们将与国际奥委会、各
Labourisoftenaccusedofrushingthroughill-consideredlawswheneveritsappearanceofcompetenceiscracking.Themental-hea
A、Hedidnotreceivetimelymedicalattention.B、Heshoutedforhelpandwasstoppedbythepolice.C、Hewastransportedtothre
Romance,whichusesnarrativeverseorprosetotellstoriesof______adventuresorotherheroicdeeds,isapopularliteraryf
Arareandcomplicatedproceduretoseparatetwinsconjoinedattheheadextendedbeyond56hoursMondayassurgeonsinSingapor
随机试题
脊柱的体表定位标志,与胸骨剑突在同一平面的椎体是
A.曲马多B.美沙酮C.胰岛素D.麦角新碱E.司可巴比妥属于第二类精神药品的是()。
下列情形属于信用证欺诈的有()
工程项目施工过程中,质量监督机构的职责有()
关于暂列金额,下列说法错误的是()。
交易所会员如对结算结果有异议()。
甲企业为工业企业,拥有三幢房产,分别为厂房A、厂房B和一幢办公楼,其中厂房A为与乙企业和丙企业共同共有,2017年有关甲企业房产的事项如下。(1)甲企业准备将厂房A进行内部装修,添置新的附属设施,经查,甲、乙、丙三个企业事先均没有约定处理方式,甲企业与乙
人的心理是一种动态的活动过程,包括________、情绪过程和意志过程。它们从不同的角度能动地反映着客观世界的事物及其关系。
“抽象与具体相结合”是数学教学原则中的内容。怎样理解数学的抽象性与具体性;
定积分x2(sinx+1)dx=___________.
最新回复
(
0
)